Go to main content

Back to integrum.se

SV EN

R5__6572

Press releases

Published: 13 June 2024 Regulatorisk

Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million

Published: 13 June 2024 Icke-regulatorisk

Integrum signs Memorandum of Understanding with Coapt for the use of its pattern recognition technology with the e-OPRA[TM] Implant System

Published: 10 June 2024 Regulatorisk

Integrum enters collaboration and distribution agreement with Hanger – the leading provider of amputee care and prosthetics in the US

Published: 30 May 2024 Regulatorisk

A Record Year in Sales

Published: 29 May 2024 Regulatorisk

Integrum receives market approval for OPRA[® in Israel]

Published: 24 May 2024 Icke-regulatorisk

Integrum AB: Invitation to the Fourth Quarter 2023/24 Results Presentation

Published: 15 May 2024 Icke-regulatorisk

Integrum has been granted a registered trademark for OPRA® Implant System in the EU

Published: 3 May 2024 Icke-regulatorisk

Integrum launches short video documentary to showcase the company’s efforts to treat combat amputees in Ukraine

Published: 2 May 2024 Icke-regulatorisk

Integrum expands its product offering to the United Kingdom market

Published: 26 March 2024 Icke-regulatorisk

Integrum expands its product offering into the Israeli market

Published: 19 March 2024 Icke-regulatorisk

Health economic study shows positive outcome using Integrum’s OPRA[TM] Implant System over socket prostheses in transfemoral amputees

Published: 29 February 2024 Regulatorisk

CORRECTION A new record revenue quarter with 61% growth

Cookies

This website uses cookiesfor statistics and user experience.